Uren; Aykut

Patent Applications and Registrations

Patent applications and USPTO patent grants for Uren; Aykut.The latest application filed is for "cd99 inhibitors and their uses".

Company Profile

0.17.15

Uren; Aykut - Rockville MD
Uren; Aykut - Baltimore MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
CD99 inhibitors and their uses Grant 11,202,792 - Uren , et al. December 21, 2	2021-12-21
CD99 Inhibitors and Their Uses App 20190262370 - Uren; Aykut ; et al.	2019-08-29
Novel Ezrin Inhibitors and Methods of Making and Using App 20180148437 - Brown; Milton L. ; et al.	2018-05-31
Targeting of EWS-FLI1 as anti-tumor therapy Grant 9,758,481 - Toretsky , et al. September 12, 2	2017-09-12
Methods and compositions for treating Ewings sarcoma family of tumors Grant 9,714,222 - Toretsky , et al. July 25, 2	2017-07-25
Methods And Compositions For Treating Cancer App 20170157089 - Toretsky; Jeffrey A. ; et al.	2017-06-08
Ezrin inhibitors and methods of making and using Grant 9,522,908 - Brown , et al. December 20, 2	2016-12-20
Methods and compositions for treating cancer Grant 9,511,050 - Toretsky , et al. December 6, 2	2016-12-06
Methods And Compositions For Treating Cancer App 20160263086 - Toretsky; Jeffrey A. ; et al.	2016-09-15
Methods And Compositions For Treating Ewings Sarcoma Family Of Tumors App 20160159741 - Toretsky; Jeffrey A. ; et al.	2016-06-09
Methods and compositions for treating Ewings sarcoma family of tumors Grant 9,290,449 - Toretsky , et al. March 22, 2	2016-03-22
Targeting Of Ews-fli1 As Anti-tumor Therapy App 20150329488 - Toretsky; Jeffrey A. ; et al.	2015-11-19
Targeting of EWS-FLI1 as anti-tumor therapy Grant 9,045,415 - Toretsky , et al. June 2, 2	2015-06-02
Methods And Compositions For Treating Ewings Sarcoma Family Of Tumors App 20150051260 - Toretsky; Jeffrey A. ; et al.	2015-02-19
Methods of use of fragments of secreted frizzled related protein, sFRP Grant 8,735,355 - Rubin , et al. May 27, 2	2014-05-27
Novel Ezrin Inhibitors And Methods Of Making And Using App 20140135325 - Brown; Milton L. ; et al.	2014-05-15
sFRP and peptide motifs that interact with sFRP and methods of their use Grant 8,334,260 - Rubin , et al. December 18, 2	2012-12-18
Secreted Frizzled Related Protein, Sfrp, Fragments And Methods Of Use Thereof App 20120202749 - Rubin; Jeffrey S. ; et al.	2012-08-09
Targeting of EWS-FLI1 as anti-tumor therapy Grant 8,232,310 - Toretsky , et al. July 31, 2	2012-07-31
Fragments of secreted frizzled related protein Grant 8,158,603 - Rubin , et al. April 17, 2	2012-04-17
Secreted Frizzled Related Protein, Sfrp, Fragments And Methods Of Use Thereof App 20110177554 - RUBIN; JEFFREY S. ; et al.	2011-07-21
Secreted frizzled related protein, sFRP, fragments and methods of use thereof Grant 7,947,651 - Rubin , et al. May 24, 2	2011-05-24
Targeting Of Ews-fli1 As Anti-tumor Therapy App 20100167994 - Toretsky; Jeffrey A. ; et al.	2010-07-01
Targeting Of Ews-fli1 As Anti-tumor Therapy App 20100004179 - Toretsky; Jeffrey A. ; et al.	2010-01-07
SFRP and peptide motifs that interact with SFRP and methods of their use Grant 7,488,710 - Rubin , et al. February 10, 2	2009-02-10
SECRETED FRIZZLED RELATED PROTEIN, sFRP, FRAGMENTS AND METHODS OF USE THEREOF App 20080207504 - Rubin; Jeffrey S. ; et al.	2008-08-28
Secreted frizzled related protein fragments Grant 7,223,853 - Reichsman , et al. May 29, 2	2007-05-29
Sfrp and peptide motifs that interact with sfrp and methods of their use App 20040077828 - Rubin, Jeffrey S. ; et al.	2004-04-22
Secreted frizzled related protein,sFRP, fragments and methods of use thereof App 20030187223 - Reichsman, Frieda ; et al.	2003-10-02
Secreted frizzled related protein, sFRP, fragments and methods of use thereof Grant 6,600,018 - Rubin , et al. July 29, 2	2003-07-29

Company Registrations

NCAGE Code	4LW56	UREN AYKUT
CAGE Code	4LW56	UREN, AYKUT

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.